Significant (greater than $10000) relationship. DCRI has numerous grants and contracts sponsored by industry. These include the following: Aastrom Biosciences ; Abbott ; Abiomed ; Acom Cardiovascular ; Adolor Corp. ; Advanced Cardiovascular Systems ; Advanced Stent Technologies ; Adynnx; Aijnomoto ; Allergan ; Amgen ; Alnylam Pharma ; Alpharma ; Amylin Pharmaceuticals ; Anadys ; Anesiva ; Angel Medical Systems ; ANGES MG ; Angiomedtrix ; APT Nidus Center ; ASCA Biopharma ; Astellas Pharma ; Asklepios ; AstraZeneca ; Atritech ; Attention Therapeutics ; Aventis ; Baxter ; Bayer ; Berlex ; BG Medicine ; Biogen ; Biolex Therapeutics ; Biomarker Factory ; Biosite ; Boehringer Ingelheim Biogen ; Boston Scientific ; Bristol-Myers Squibb ; BMS Pfizer ; Carbomed ; CardioDx ; CardioKinetix ; Cardiovascular Systems ; Cardiovax ; Celsion Corp. ; Centocor ; Cerexa ; Chase Medical ; Conatus Pharmaceuticals ; Conor Medsystems ; Cortex ; Corgentech ; CSL Behring ; CV Therapeutics ; Daiichi Pharmaceuticals ; Daiichi Sankyo ; Daiichi Sankyo Lilly ; Datascope; Dendreon ; Dainippon ; Dr. Reddy s Laboratories; Eclipse Surgical Technologies ; Edwards Lifesciences ; Eisai ; Endicor ; EnteroMedics ; Enzon Pharmaceuticals ; Eli Lilly ; Ethicon ; Ev3 ; Evalve ; F2G ; Flow Cardia ; Fox Hollow Pharmaceuticals ; Fujisawa ; Genetech ; General Electric ; General Electric Co. ; General Electric Healthcare ; General Electric Medical Systems ; Genzyme Corp. ; Genome Canada ; Gilead Sciences ; GlaxoSmithKline ; Guidant Corp. ; Heartscape Technologies ; Hoffman-LaRoche ; Hospira ; Idera Pharmaceuticals ; Ikaria ; Imcor Pharmaceuticals ; Immunex ; INFORMD ; Inimex ; Inspire Pharmaceuticals ; Ischemix ; Janssen ; Johnson and Johnson ; Jomed ; Juventus Therapeutics ; KAI Pharmaceuticals ; King Pharmaceuticals ; Kyowa Pharma ; Luitpold ; Mardil ; MedImmune ; Medscape ; Medtronic Diabetes ; Medtronic ; Medtronic Vascular ; Merck Group ; MicroMed Technology ; Millennium Pharmaceuticals ; Mitsubishi Tanabe ; Momenta ; Nabriva ; Neuron Pharmaceuticals ; NitroMed; NovaCardia Inc ; Novartis AG Group ; Novartis Pharmaceuticals ; Oncura ; Orexigen ; Ortho-McNeil-Janssen ; OSI Eyetech ; OSI Pharmaceuticals ; Pfizer ; Pharmacyclics ; Pharmasset ; Pharmos ; Phyxius Pharmaceuticals; Pharsight ; Pluristen Therapeutics ; Portola Pharmaceuticals ; Proventys ; Radiant ; Regado Biosciences ; Rengeneron Pharmaceuticals ; Roche Molecular Systems ; Roche Group ; Roche Diagnostic ; Salix Pharmaceuticals ; Sanofi-Pasteur, Inc; Sanofi-aventis ; Santaris Pharmaceuticals ; Schering-Plough ; Scios ; Siemens ; Southwest Oncology Group ; Spectranetics ; Summit ; Sunovion Pharmaceuticals ; TAP Pharmaceutical Products ; Tengion ; The Medicines Company ; Theravance ; TherOx ; Tethys Bioscience ; Theregen ; Three Rivers Pharmaceuticals ; The EMMES Corporation ; UCB ; Valentis ; Valleylab ; Vertex ; Viacor ; and Wyeth . 